Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6 | 7 | 0 | 0 | 0 |
| Other current assets | 7 | 57 | 0 | 0 | 0 |
| TOTAL | $109 | $141 | $96 | $23 | $51 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $109 | $141 | $96 | $23 | $51 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,628 | 5,890 | 5,952 | 5,724 | 5,751 |
| Accrued Expenses | 2,652 | 3,447 | 3,481 | 3,296 | 3,131 |
| TOTAL | $12,061 | $12,210 | $12,287 | $11,729 | $11,437 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 344 | 74 | 119 | 174 | 204 |
| TOTAL | $344 | $74 | $119 | $174 | $204 |
| Total Liabilities | $12,405 | $12,284 | $12,406 | $11,903 | $11,641 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 365,419 | 275,729 | 157,027 | 144,327 | 119,594 |
| Common Shares | 298 | 221 | 144 | 126 | 120 |
| Retained earnings | -177,565 | -177,169 | -176,488 | -176,058 | -175,768 |
| Other shareholders' equity | 811 | 672 | 22 | 22 | 22 |
| TOTAL | $-12,297 | $-12,142 | $-12,310 | $-11,880 | $-11,591 |
| Total Liabilities And Equity | $109 | $141 | $96 | $23 | $51 |